Over the last 3 months MSFT stock is off 12%, China based bio-pharma stock, CBPO is up 57%.
CBPO ( listed on Nasdaq), for the first 3 quarters, net income was up 190%, over 9 month's a year ago.
China stocks don't have a fiscal cliff, an inactive Congress, and $16 TRILLION and growing national debt.
CBPO has $4 cash per share.
China Biologic Products CBPO, is in the bio-pharmaceutical area with over 30 products and excellent leadership.
China's GDP growth is an robust 8.5% per year, with USA's GDP growth a very weak 1.7 % per year.
It may look cheap but you get what you pay for but with Chinese stocks sometimes you don't